MS · Morgan Stanley
Conviction · Medium · more likely to lead the S&P 500 over the next three months, by a modest margin
Wrong if: a daily close below $170
Note written ·
How this view changed
- · Rating raised from Low to Medium. Company news, 11 November 2026: Anthropic's IPO, led by Goldman Sachs and Morgan Stanley, moved to marketing at a proposed valuation of up to about $1.4 trillion, and bankers were weighing $1.5 trillion or more.
Price against the kill line
12.1% clear of its kill line on the 13 November 2026 close.
How to read this
The red mark is the price level of the published kill line: a close through it (a weekly close, on a weekly line) would prove the research note wrong on price. The dot is where the stock closed on 13 November 2026; a dot left of the mark has closed through its line.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close below $170.00, on record since 11 November 2026. The shares are down 12.1% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close below $170, well under the $181.44 close of 6 November 2026, which would show the November rebound has failed. Q4 2026 Wealth Management net new assets far below Q3's $232.4 billion, or an Anthropic IPO postponed past 31 December 2026, would also break the case.
Research onlyNot in the portfolio.
Catalyst
Key figures from the filings · Financials
Quarter to 30 September 2026, filed 5 November 2026; valuation at the 13 November 2026 close
- Net income, latest quarter ($M)
- 4,909
- Net income, four quarters ($M)
- 20,454
- Shareholders' equity ($M)
- 117,109
- Price to earnings (×)
- 14.6
- Price to book value (×)
- 2.5
- Revenue, latest quarter ($M)revenues net of interest expense
- 20,338
- Revenue, change on a year (%)
- +11.6
- Market value ($M)
- 297,994
Morgan Stanley is a bank: net cash, enterprise value and free cash flow are not shown, because a bank's or insurer's cash and investments back its deposits and policies.
All filed numbers
What Morgan Stanley reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) |
|---|---|---|
| first filed | 20,338 | +11.6 |
| first filed | 21,348 | +27.1 |
| first filed | 20,580 | +16.0 |
| first filed | 17,890 | +10.3 |
| first filed | 18,224 | +18.5 |
| first filed | 16,792 | +11.8 |
| Pre-tax income ($M) | 6,478 |
| Net income ($M) four quarters: 20,454 | 4,909 |
| Diluted shares, change on a year (%) against the quarter to 30 September 2025 | −1.5 |
| Operating cash flow ($M) | −58,279 |
| Capital spending ($M) | Not reported |
| Free cash flow ($M) | Not meaningful |
Not meaningful: a bank's or insurer's operating cash flow moves with its deposits, loans and policy reserves, so it is not cash free for its owners.
| Cash and short-term investments ($M) | 138,669 |
| Debt ($M) | 388,589 |
| Net cash, cash less debt ($M) | Not meaningful |
| Deferred revenue ($M) | Not reported |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | Not reported |
| Inventory ($M) | Not reported |
| Shareholders' equity ($M) | 117,109 |
Not meaningful: a bank's or insurer's cash and investments back its deposits and policies.
| Market value ($M) | 297,994 |
| Enterprise value, market value plus net debt ($M) | Not meaningful |
| Enterprise value to sales (×) | Not meaningful |
| Enterprise value to operating income (×) | Not meaningful |
| Price to earnings (×) | 14.6 |
| Price to book value (×) | 2.5 |
| Free-cash-flow yield (%) | Not meaningful |
Not meaningful: a bank's or insurer's cash and investments back its deposits and policies.
Not meaningful: a bank's or insurer's operating cash flow moves with its deposits, loans and policy reserves, so it is not cash free for its owners.
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 0.9% of shares outstanding sold short, 2.2 days of average trading to cover, −2.4% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $454K |
| 12 monthsfrom | $0 | $52.2M |
This note mentions Anthropic, the company that makes Claude, the AI model that wrote it. The same method and sources apply as on every note. The conflict of interest, stated.
The thesis
Morgan Stanley's shares have modestly better than even odds of beating the S&P 500 over the next three months. The firm co-leads Anthropic's initial public offering (IPO) and carries record wealth flows into the fourth quarter. Two events settle the case: the IPO pricing, which CNBC reported for 18 November 2026, and the fourth-quarter report, expected around 14 January 2027. Together they show whether investment banking fees and asset gathering keep growing.
The rating is Medium because the Anthropic deal now has terms and a reported date. FinanceFeeds reported on 11 November 2026 that Anthropic's amended S-1 registration statement of 10 November 2026 offers 825 million Class A shares at $70 to $78. Goldman Sachs and Morgan Stanley lead a syndicate of 22 banks named in the filing. CNBC, citing people familiar with the plans, reported pricing on 18 November 2026 and Nasdaq trading under the ticker ANT on 19 November 2026. The fee would land in an investment banking business that grew only 2% in the third quarter of 2026.
The share price shows little of this so far. The shares closed at $189.17 on 12 November 2026, below the 50-day average of $192.31 and the 200-day average of $192.41. Adjusted daily closes show a 12.4% fall over three months.
Bullish and bearish views on Morgan Stanley
The bull case on Morgan Stanley (MS), in brief: the IPO has a price range and a date. The bear case: profitability slipped in a record quarter.
Bull case
- The IPO has a price range and a date. The 10 November 2026 amended S-1 sets 825 million shares at $70 to $78, with Goldman Sachs and Morgan Stanley leading 22 banks, FinanceFeeds reported on 11 November 2026. CNBC reported pricing for 18 November 2026.
- Bankers report demand above the range. Fortune reported on 11 November 2026 a proposed valuation of up to about $1.4 trillion. Semafor, citing the Financial Times, reported the same day that bankers were weighing $1.5 trillion or more. Benzinga reported on 11 November 2026 that demand could push the price above $78 and the raise past $100 billion.
- Wealth flows hit a record. Wealth Management net new assets were $232.4 billion in the third quarter of 2026 (Q3), and fee-based flows were $80.5 billion, the company's 14 October 2026 earnings release (Form 8-K) shows.
- Wealth revenue and margin held up. Wealth Management revenues were a record $9.1 billion in Q3 2026, up 10% year on year, at a 30.4% pre-tax margin, the same release shows.
- Advisory and financing mandates keep arriving. Blackstone said on 26 October 2026 that Morgan Stanley, Bank of America and Citi arrange the first-lien debt in a $63 billion package financing Broadcom AI hardware leased to Anthropic. Company news on 4 November 2026 named Morgan Stanley and Citi as managers of Meta's first euro bond. Company news on 12 November 2026 reported Morgan Stanley's appointment as lead adviser on the sale of Metro Bank.
- Private-market services are growing by acquisition. The company agreed on 9 November 2026 to buy Vinyl Equity, a digital transfer agent, with closing expected in the first quarter of 2027. Banking Dive, citing Bloomberg, reported about $65 million of integration costs over a couple of years.
- Capital returns continue. The company repurchased $1.5 billion of shares in Q3 2026, declared a $1.15 quarterly dividend and reported a 14.9% Standardized common equity tier 1 (CET1) capital ratio at 30 September 2026, according to the 14 October 2026 release.
- Analysts' targets sit above the price. StockAnalysis showed a $211.50 consensus target across 26 analysts on 11 November 2026, with a $206.50 median and a consensus Buy rating. Barclays kept a $262 target on 6 November 2026.
Bear case
- Profitability slipped in a record quarter. Return on tangible common equity (ROTCE) was 22.6% in Q3 2026, against 23.5% a year earlier, according to the 14 October 2026 release.
- Banking and bond trading lag. Investment banking revenues rose only 2% to $2.2 billion in Q3 2026, and fixed income revenues fell 7% to $2.0 billion, the same release shows.
- Equity trading starts from a high base. Equity revenues rose 41% to $5.8 billion in Q3 2026, per the release. A calmer fourth-quarter market would compare poorly with that level.
- The IPO fee is shared widely. The 10 November 2026 amended S-1 names 22 banks in the syndicate, FinanceFeeds reported. Morgan Stanley also arranges first-lien debt on hardware leased to Anthropic, per Blackstone's 26 October 2026 release. A weak debut would hit fees and sentiment at once.
- Private credit sits close to the wealth franchise. InvestmentNews reported that Morgan Stanley and JPMorgan turned cautious on private credit as redemptions surged. The firm's North Haven Private Income Fund caps quarterly repurchases at 5% of shares.
- Rates may move against bank shares. The Federal Reserve held its target range at 3.75%-4.00% on 28 October 2026, and two officials dissented in favour of a quarter-point hike, CNBC reported.
- The lowest target is close to the price. StockAnalysis showed a $185 low target on 11 November 2026, under the $189.17 close of 12 November 2026.
Price setup
The shares closed at $181.44 on 6 November 2026, the low point before the November rebound. They then closed at $187.10 on 9 November 2026, $187.56 on 10 November 2026, $190.61 on 11 November 2026 and $189.17 on 12 November 2026. The rebound has carried the shares to just under the 50-day and 200-day averages, which sit almost level at $192.31 and $192.41 as of 12 November 2026. A sustained move above both would show the post-results slide has ended.
The wider range runs from a 52-week closing low of $154.37 on 12 March 2026 to an intraday high of $232.25 on 15 July 2026. The last close sits 18.5% below that high. SEC Form 4 filings trace the autumn decline. Mitsubishi UFJ Financial Group, a 10% owner, disposed of shares to the company at $212.57 on 22 September 2026 and at $183.84 on 29 October 2026, both under a Rule 10b5-1 plan. Director Judith Miscik sold 2,480 shares at $183.21 on 6 November 2026, a Form 4 filed 10 November 2026 shows.
The market prices the shares below analysts' path. Benzinga put the market value at $292.81 billion on 10 November 2026, and the $189.17 close of 12 November 2026 sits under StockAnalysis's $206.50 median target. The price reflects slow investment banking growth and private-credit worries more than a fee from a record IPO.
Catalysts ahead
- ~18 November 2026 (est.): Anthropic IPO pricing, with Nasdaq trading under ANT reported for 19 November 2026; Goldman Sachs and Morgan Stanley lead. Pricing at or above the $70 to $78 range would put a large underwriting fee into fourth-quarter investment banking revenue; a delay or a price below the range would remove or shrink it.
- 9 December 2026: Federal Reserve rate decision at the December FOMC meeting. Two officials dissented for a hike on 28 October 2026; a December increase would lift yields and test whether bank shares hold their November rebound.
- ~31 December 2026 (est.): Quarterly repurchase window at the North Haven Private Income Fund. Redemption demand above the fund's 5% cap would keep private-credit worries attached to the wealth franchise and could slow asset gathering.
- ~14 January 2027 (est.): Morgan Stanley Q4 2026 results, before the US market opens. Shows whether net new assets stay near Q3's record $232.4 billion and whether investment banking growth improves on Q3's 2% with the Anthropic fee included.
What would change the view
A daily close below $170, well under the $181.44 close of 6 November 2026, which would show the November rebound has failed. Q4 2026 Wealth Management net new assets far below Q3's $232.4 billion, or an Anthropic IPO postponed past 31 December 2026, would also break the case.
The risks this note tracks, each with what would confirm it:
- The Anthropic IPO slips or prices weakly, removing the largest expected fee of the quarter. Confirmed by: a postponement past 31 December 2026, or pricing below the $70 to $78 range set in the 10 November 2026 amended S-1.
- Q3's record wealth flows prove to be a one-off, and asset gathering drops back. Confirmed by: Q4 2026 Wealth Management net new assets well below Q3's $232.4 billion in the mid-January report.
- Investment banking keeps growing slowly while trading cools from strong Q3 levels. Confirmed by: another quarter of low single-digit investment banking growth, or equity revenues falling from Q3's $5.8 billion.
- Private-credit or single-borrower AI-compute lending leads to write-downs or tighter capital treatment. Confirmed by: a sharp rise in the provision for credit losses tied to private credit or the Broadcom-Anthropic loans, or a reported supervisory finding against the bank.
- Sector-wide selling in bank stocks resumes on higher yields regardless of company results. Confirmed by: a Fed hike at the 9 December 2026 meeting, or the KBW Nasdaq Bank Index making new lows.
What it trades with
Morgan Stanley trades with the large US banks and brokers. The KBW Nasdaq Bank Index and Treasury yields are the main outside drivers of the shares. Goldman Sachs shares the Anthropic lead, so both stocks carry the same deal outcome, and Anthropic's first weeks of trading will move sentiment toward AI financing more broadly. Wealth Management fee revenue depends on client asset levels, which ties the business to US equity prices: a broad market decline would hit both the shares and wealth earnings. The Q3 2026 equity trading surge depends on high market activity, and a calmer market would reduce it across all the trading banks at once.
The evidence, claim by claim (8)
- Q3 2026 diluted EPS was $3.03 against $2.80 a year earlier; ROTCE was 22.6% against 23.5%. Morgan Stanley Q3 2026 earnings release (Form 8-K), 14 October 2026 · as of
- Wealth Management Q3 2026 revenues were $9.1 billion, up 10% year on year, at a 30.4% pre-tax margin; net new assets were $232.4 billion and fee-based flows $80.5 billion. Morgan Stanley Q3 2026 earnings release (Form 8-K), 14 October 2026 · as of
- Q3 2026 equity revenues were $5.8 billion, up 41% year on year; fixed income revenues were $2.0 billion, down 7%; investment banking revenues were $2.2 billion, up 2%. Morgan Stanley Q3 2026 earnings release (Form 8-K), 14 October 2026 · as of
- The company repurchased $1.5 billion of shares in Q3 2026, declared a $1.15 quarterly dividend and reported a 14.9% Standardized CET1 ratio. Morgan Stanley Q3 2026 earnings release (Form 8-K), 14 October 2026 · as of
- Anthropic's amended S-1 offers 825 million Class A shares at $70 to $78; Goldman Sachs and Morgan Stanley lead a 22-bank syndicate. Anthropic S-1/A dated 10 November 2026, as reported by FinanceFeeds 11 November 2026 · as of
- Anthropic set a proposed IPO valuation of up to about $1.4 trillion; bankers were weighing $1.5 trillion or more. Fortune and Semafor (citing the Financial Times), 11 November 2026 · as of
- Consensus 12-month target was $211.50 across 26 analysts, with a $206.50 median, a $185 to $262 range and a Buy rating; Barclays kept $262 on 6 November 2026. StockAnalysis MS forecast page · as of
- Director Judith Miscik sold 2,480 shares at $183.21 in an open-market sale on 6 November 2026. SEC Form 4 filed 10 November 2026 · as of
Sources
- Anthropic IPO Date: $70-$78 Price Range Set, Trading Reported From 19 November · financefeeds.com ·
- Morgan Stanley Reports Third Quarter 2026 Earnings Results · morningstar.com ·
- Anthropic sets a $1.4 trillion IPO target, but bankers may already be aiming higher · fortune.com ·
- Anthropic's bankers mull raising IPO valuation to $1.5T · semafor.com
- Morgan Stanley (MS) · stockanalysis.com ·
- Banking Dive
- Morgan Stanley to Acquire Vinyl Equity · morganstanley.com
- Morgan Stanley, JPMorgan turn cautious on private credit as redemptions surge · investmentnews.com
Related · shared themes
AAMI
Acadian Asset Management
Acadian Asset Management's eleven straight quarters of client inflows, record fees and resumed buybacks give its shares a modest edge over…
C
Citigroup
Citigroup is modestly more likely to beat the S&P 500 over three months: its returns beat its 11% target while the shares fell 10.5% on…
HIPO
Hippo Holdings
Hippo Holdings has modestly better-than-even odds of beating the S&P 500 after it raised 2026 profit guidance on 29 October 2026 on a…
PRCH
Porch Group
Porch Group's insurance fees beat in Q3 2026 and lifted 2026 adjusted EBITDA guidance to $135-140M, and the shares hit a 52-week high on 10…